SUMMARY Agar dilution breakpoint susceptibility testing using GC, DST, and proteose agars, was performed on consecutive clinical isolates of non-penicillinase producing Neisseria gonorrhoeae to examine the feasibility of using such a system in a diagnostic laboratory. The incidence and level of resistance to penicillin and spectinomycin was also assessed. On DST medium 93 The methods used in this study could be applied in a routine diagnostic laboratory for immediate clinical benefit and long term epidemiological studies. To enable direct comparisons to be made between populations at different centres, however, methods for gonococcal susceptibility testing need to be standardised.
The retrospective antibiotic susceptibility testing of Neisseria gonorrhoeae used to be regarded as oflimited value as most patients would already have been successfully treated empirically on the basis of a Gram stain. The long standing problem of chromosomal resistance to penicillin' was overcome by using increased doses of penicillin, but the increased incidence of clinically important chromosomal resistance to penicillin23 and resistance due to f-lactamase production4 requires the use of other antibiotics. Unfortunately, gonococci are now showing resistance to appropriate alternatives, such as spectinomycin56 and tetracycline.7 There are no rapid tests for nonenzymic gonococcal resistance to f-lactam antibiotics.
These changing patterns of resistance therefore necessitate continuous surveillance by susceptibility testing to enable rational empirical treatment to be planned in different geographical areas.
In this study we examined the feasibility of using agar dilution breakpoint susceptibility testing in a diagnostic laboratory. This method of susceptibility testing determines the presence or absence of growth ofan isolate on agar containing antibiotic. The use ofa few select antibiotic concentrations, rather than the full range of concentrations used in conventional minimum inhibitory concentration (MIC) determinaAccepted for publication 7 April 1988 tion, enables isolates to be allocated to susceptibility categories. Each antibiotic concentration used in this technique is known as a "breakpoint".
We used agar dilution breakpoint susceptibility testing to assess the incidence and level of resistance to spectinomycin, the first line treatment of uncomplicated anogenital gonorrhoea at the Praed Street clinic for sexually transmitted diseases, and to penicillin. Isolates were also auxotyped and serotyped to provide further epidemiological information.
Material and methods

STRAINS
During August to October 1986, 300 clinical isolates of Neisseria gonorrhoeae were collected. Antibiotic susceptibility testing was performed on the day of isolation. The first 200 consecutive isolates were tested only for their antibiotic susceptibility. The subsequent 100 consecutive isolates were also auxotyped and serotyped. Although these strains were almost entirely from the Praed Street clinic for sexually transmitted diseases, London, a small number came from gynaecology outpatient clinics or general practitioners' patients. They were isolated on GC agar base (BBL) supplemented with 1% IsoVitaleX. This medium also contained amphotericin B (I 5 mg/l), colistin (1000 ig/ 1), trimethoprim (5 mg/I) and vancomycin (3 mg/l). Data were analysed using the Statistical Package for Social Sciences (SPSS). The significance of differences in distributions was determined using the Mann-Whitney U test for significance between two media.
Results
Of the 200 isolates initially examined, 86 (43%) were from women, 107 (53 5%) were from the urethra of men, and seven (3.5%) were from the rectum of men.
The further 100 isolates tested comprised 46 (46%) from women, 52 (52%) from the urethra of men, and two (2%) from the rectum of men.
In the 100 consecutive isolates auxotyped we found that 38 (38%) were prototrophic, 26 (26%) were arginine-, hypoxanthine-, and uracil-requiring (AHU) and 19 (19%) were proline-requiring (Pro). The remaining 17 (17%) of isolates were of six other auxotypes. We detected 18 serovars in the 100 isolates serotyped. The most common of these were PrIB-3 (36/100; 36%), PrIA-10 (15/100; 15%), and PrIA-2 (12/100; 12%). A total of 37 auxotype/serovar (A/S) classes were thus present in this population.
ANTIBIOTIC SUSCEPTIBILITY DISTRIBUTIONS Gill, Ison Table 3 shows the susceptibility to penicillin and spectinomycin of the WHO and CDC control strains determined on GC, DST, and proteose agars, together with their reference laboratory values. (For the WHO strains reference values were determined on Difco blood agar No 5 supplemented with lysed horse blood and an inoculum of 0I organisms (personal communication Gonococcal Reference Laboratory, Bristol). The reference laboratory values of the CDC strains were determined on Proteose No 3 agar (Difco) supplemented with 1% haemoglobin and 1% IsoVitaleX). We again found discrepancies in susceptibility categorisation-for example, WHO strain B was categorised as "sensitive" on DST and proteose agars but showed "intermediate resistance" on GC agar.
Where discrepancies occurred between the results on different media, isolates always seemed to be more resistant on GC agar than on DST agar. Discrepancies that occurred between breakpoints when comparing GC and proteose agars, and between those when comparing DST and proteose agars, showed no clear pattern. Table 4 shows the susceptibility to penicillin and spectinomycin of the UKNEQAS strains8 determined on GC and DST agars. The reference laboratory values quoted were determined on Oxoid Isosensitest agar supplemented with 5% chocolated horse blood. With only one exception, results of our susceptibility testing show agreement within a one doubling dilution error of the reference laboratory values. Strain 1312 with a reference laboratory penicillin MIC of0-03 mg/l ("sensitive"), was categorised as showing "intermediate resistance". This discrepancy may be due to the use of a different medium for testing together with a one dilution experimental error. Only one or two colonies of an isolate were required to prepare sufficient suspension for inoculating plates containing antibiotic. This allowed susceptibility testing to be started on the morning ofisolation when only presumptive identification had been made, and therefore resulted in the unnecessary testing of a small number of pharyngeal meningococci. While growth on DST agar was sufficient to allow end points to be read at 24 hours, the more luxuriant growth on proteose and GC agars made their end points easier to read at this time. A faint haze produced on DST agar, which might be confused with a light growth, was from the inoculum itself. No difference in end point, however, was detected when plates were read at 24 and 48 hours. This resulted in susceptibility results being available at the same time as identification by sugar utilisation tests, producing a minimum delay in reporting to clinicians.
Discussion
Agar dilution methods have several advantages over disc diffusion methods of susceptibility testing. The antibiotic susceptibility of several organisms may be tested on each plate, the end point is easily read as presence or absence of growth, standardisation of the inoculum is less critical, and reproducibility between laboratories is better.'2 With disc diffusion methods, inoculum standardisation is more critical and, together with variations in the method of measuring zone size, has been cited as a major cause of interlaboratory variation.'2"3 The UKNEQAS study of susceptibility testing of Neisseria gonorrhoeae8
found an association between error rates and the antibiotic content ofthe discs used. Laboratories using high content tetracycline discs (25, 30, or 100 pg) made proportionately more errors than those using low content discs (2, 5, or 10 Mg). Those laboratories using low content spectinomycin discs (10 or 16 gg), however, made more errors than those using a higher disc content (25, 30, or 100 Mg). We have also found no direct correlation between the MIC determined by agar dilution and the size of zone of inhibition of growth in disc diffusion susceptibility tests performed on Neisseria gonorrhoeae (CA Ison and CSF Easmon, unpublished data). The disc method gave larger zones of inhibition of growth of highly sensitive isolates when compared with the zones produced with isolates of reduced susceptibility. Pronounced variation in 981 strain growth rates, however, prevented the use ofdisc methods to calculate accurately MICs in the manner of the Kirby-Bauer method (Federal Register, 1972, September 30) .'4 Broth dilution methods are unsuitable for the susceptibility testing of gonococci as these organisms grow poorly in liquid media. For these reasons, agar dilution methods are regarded as the most suitable for epidemiological studies of antimicrobial susceptibility. We did not use a full range of antibiotic concentrations as the preparation and inoculation of the large number of plates necessary would have produced an unacceptable increase in workload in the diagnostic laboratory. Instead, we chose breakpoints which produce the most useful results both clinically and epidemiologically. These breakpoints may require revision as changes in antimicrobial resistance occur.
Agar dilution breakpoint susceptibility testing of gonococci is feasible in a routine diagnostic laboratory. In common with the International Collaborative Study,'2 we found no detectable loss in the antimicrobial activity of plates containing antibiotic stored in sealed bags at 4°C for 10 days. This enabled batches of plates to be prepared at the end of one working week for the following week. The ability to read end points at 24 hours rather than 48 hours minimised delays in reporting susceptibilities to clinicians.
The medium used for testing seems to affect the distribution of gonococcal susceptibility to both spectinomycin and penicillin. With the former, changes seen may well have fallen within the limits of experimental error. With penicillin, variation was more definite although not significant. The use of spectinomycin as first line treatment in uncomplicated anogenital gonorrhoea at the Praed Street clinic, prevented us from assessing the clinical importance of strains reported as "sensitive" when tested on one medium but which seemed to be more resistant on another. This would need to be resolved by a large clinical trial. The effect of different media on the in vitro susceptibility of gonococci has also been shown by other workers.'4 Changes in susceptibility can vary with the antibiotic tested and the media used for testing. For example, Woodford and Ison, working in this laboratory, have shown that isolates may seem to be less susceptible to erythromycin but more susceptible to tetracycline on GC agar than on DST agar. '5 Unfortunately, at present no internationally accepted method of susceptibility testing gonococci has been agreed. The Centers for Disease Control, Atlanta, which until recently had used Proteose No 3 agar supplemented with haemoglobin and IsoVitaleX, now recommend the use of GC agar with IsoVitaleX for agar dilution susceptibility testing'6; neither of these media were developed specifically for susceptibility Gill, Ison testing. The WHO recommends the use of DST agar supplemented with haemoglobin and IsoVitaleX (I Lind, personal communication). We recommend using a defined susceptibility testing medium, and will continue to use DST agar supplemented with lysed blood and IsoVitaleX at present. International agreement on the choice of medium for susceptibility testing Neisseria gonorrhoeae is needed.
The heterogeneity of our population of clinical isolates is indicated by finding 37 A/S classes in 100 isolates. Similar heterogeneity has been shown in other populations and has caused concern about how well certain sampling methods represent patterns of antibiotic resistance. Rice et al found, by using A/S classification, that discontinuous sampling could delay the detection of strains newly introduced into a population or overestimate the importance of transient strains.'7 They suggested that this problem would not occur if systematic longitudinal sampling was used. Persistent strains would also be readily detected by such sampling.
The methods used in this study could be applied in a routine diagnostic laboratory for immediate clinical benefit and to provide the necessary longitudinal sampling for long term epidemiological studies. To enable direct comparisons to be made between populations at different centres, however, methodology needs to be standardised.
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